IP Verse

Ointments For The Topical Treatment Of Psoriasis - EP3146969

The patent EP3146969 was granted to LEO Pharma on Jun 20, 2018. The application was originally filed on Jan 27, 2000 under application number EP16185207A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3146969

LEO PHARMA
Application Number
EP16185207A
Filing Date
Jan 27, 2000
Status
Granted And Under Opposition
May 18, 2018
Grant Date
Jun 20, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZDec 21, 2018GREINERWITHDRAWN

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5565462
OPPOSITIONWO0064450
OPPOSITIONWO9414453
OTHEREP2455083
SEARCHEP0129003
SEARCHWO9414453

Non-Patent Literature (NPL) Citations (33) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- KRAGBALLE, K. ET AL., BR J DERMATOL, (199810), vol. 139, no. 4, pages 649 - 54-
DESCRIPTION- ORTONNE, J.P., NOUV. DERMATOL., (1994), vol. 13, no. 10, pages 746 - 751-
DESCRIPTION- RICHARDS, H.L. ET AL., J AM ACAD DERMATOL, (199910), vol. 41, no. 4, pages 581 - 3-
DESCRIPTION- RUZICKA, T.; LORENZ, B., BR J DERMATOL, (1998), vol. 138, no. 2, pages 254 - 58-
EXAMINATION- PETER VAN DE KERKHOF ET AL, "Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris", CURRENT MEDICAL RESEARCH AND OPINION, GB, (20110118), vol. 27, no. 1, doi:10.1185/03007995.2010.541005, ISSN 0300-7995, pages 225 - 238, XP055386643
OPPOSITION- BARNETSON et al., "The use of corticosteroids in dermatological practice", Med. J. Austr., (19920000), vol. 156, pages 428 - 431, XP055386641-
OPPOSITION- "betamethasone", Wlter Lund, The Pharmaceutical Codex, (19940000), pages 765 - 769, XP055542857-
OPPOSITION- "Betnovate Ointment", medicines.org.uk, (20130924), URL: https://www.medicines.org.uk/emc/printfriendlydocument.aspx?documentid=712, XP055542184-
OPPOSITION- "chapter 12", Bauer et al, Pharmazeutische Technologie, Stuttgart, (19970000), pages 266 - 267, XP055542195-
OPPOSITION- "chapter15", nurnberg et al, Textbook Hagers Handbuch der pharmazeutischen Praxis, Berlin875, (19910000), vol. 2, pages 871 - 875, XP055542816-
OPPOSITION- "chapter 3.1.1", Hornstein et al, Externe Therapie von Hautkrankheiten, Stuttgart, (19850000), pages 44 - 48, XP055542174-
OPPOSITION- "chapter 38", Elisabeth B.Vadas, Remington: The Science and Practice of Pharmacy, (19950000), pages 639 - 647, XP055542826-
OPPOSITION- "chapter 83", Galen W.Radebaugh et al, Remington: The Science and Practice of Pharmacy, (19950000), pages 1447 - 1462, XP055542832-
OPPOSITION- "Chapter 8: Vitamin D3 Analogues", van de Kerkhof, Textbook of Psoriasis, Oxford, pages 121 - 147, 00001999, XP055386626-
OPPOSITION- "dosierung und dosis-bzw konzentrations wirkungs beziehungen", MUTSCHLER, Arzneimittelwirkungen, 7th edition, Wissenschaftliche Verlagsgesellschaft, Stuttgart, (19960000), page 74, XP055542850-
OPPOSITION- "Halbfeste Zubereitungen zur kutanen Anwendung", Europäisches Arzneibuch, page 1316-
OPPOSITION- KRAGBALLE, K., "Vitamin D3 analogues", Dermatologic Clinics, (19950000), vol. 13, no. 4, pages 835 - 839, XP009147020-
OPPOSITION- LEBWOHL, M., "Topical application of calcipotriene and corticosteroids: combination regimens.", J Am Acad Dermatol, (19970000), vol. 37, pages S55 - S58, XP055386630-
OPPOSITION- ORTONNE, J., "Psiorasis: new therapeutic modality by calcipotriol and betamethasone dipropionate", Nouv Dermatol, (19940000), vol. 13, no. 10, pages 746 - 751, XP003025977-
OPPOSITION- "Pocket Dosing Guide", PDR (The Physician's Desk Reference), (20020000), pages 152 - 153, XP055542217-
OPPOSITION- PATEL, B. et al., "COMPATIBILITY OF CALCIPOTRIENE WITH OTHER TOPICAL MEDICATIONS", Journal of the American Academy of Dermatology, (19980000), vol. 38, no. 6, pages 1010 - 1011, XP009047646
OPPOSITION- RUZICKA, T. et al., "Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, doucle-blind, randomized study", British Journal of Dermatology, (19980000), vol. 138, pages 254 - 258, XP002900975
OPPOSITION- KRAGBALLE, K. et al., "Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy", British Journal of Dermatology, (19980000), vol. 139, pages 649 - 654, XP055386634
OPPOSITION- SIMONSEN et al., "Development of a New Formulation Combining Calcipotriol and Betamethasone Dipropionate in an Ointment Vehicle", Drug Development and Industrial Pharmacy, (20040000), vol. 30, no. 10, pages 1095 - 1102, XP055386991
OPPOSITION- VAN DER KERKHOF, P. et al., "Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris", Current Medical Research and Opinion, (20110000), vol. 27, no. 1, pages 225 - 238, XP055386643
OTHER- ORTONNE, "Psoriasis: new therapeutic modality by calcipotriol and betamethasone dipropionate", Nouv. Dermatol., (19940000), vol. 13, no. 10, pages 746 - 751, XP003025977-
OTHER- RUZICKA, "Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, doucle-blind, randomized study", British Journal of Dermatology, (19980000), vol. 138, pages 254 - 258, XP002900975
OTHER- PETER VAN DE KERKHOF et al., "Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris", Current Medical Research and Opinion, (20110118), vol. 27, no. 1, pages 225 - 238, XP055386643
SEARCH[ ] - BR. J. DERMATOL., (1996), vol. 135, no. 3, pages 379 - 384-
SEARCH- GLADE C P ET AL, "Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of", STN INTERN. FILE CAPLUS, (1996), Database accession no. 125:266250, URL: CAPLUS, XP002900974 [A] 1-14 * abstract *-
SEARCH- ORTONNE J P, "Psoriasis: new therapeutic modality by calcipotriol and betamethasone dipropionate", NOUV. DERMATOL,, (1994), vol. 13, no. 10, pages 746 - 751, XP003025977 [A] 1-14 * the whole document *-
SEARCH- PATEL B ET AL, "COMPATIBILITY OF CALCIPOTRIENE WITH OTHER TOPICAL MEDICATIONS", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY, INC, US, (199806), vol. 38, no. 6, PART 01, doi:10.1016/S0190-9622(98)70171-9, ISSN 0190-9622, XP009047646 [I] 1,2,5-7,9,10,12,13 * the whole document * [A] 3,4,8,11,14
SEARCH- RUZICKA T ET AL, "Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, doucle-blind, randomized study", BRITISH JOURNAL OF DERMATOLOGY, (1998), vol. 138, pages 254 - 258, XP002900975 [A] 1-14 * page 257 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents